The investigators sought to compare the efficacy and safety of methotrexate to treat psoriasis in patients with and without psoriatic arthritis.

Xellia announced that the Food and Drug Administration (FDA) has approved its Premixed Vancomycin Injection in a Ready-to-Use bag.

The main finding of this study was that the numbers of CD4+T, CD8+T, CD19+B, and CD56+NK cells were significantly reduced by treatment with FAEs.

Patients with psoriasis reported significantly higher values for parameters that address periodontal inflammation.

The NDA included data from the Phase 3 REVIVE-1 and REVIVE-2 trials.

Patients with PsA and severe skin manifestations had earlier onset and axial disease.

Over the study period, significant increases in the number of screening tests, as well as the ratio between the tests and hospital admissions, was observed.

E-mail accounts and passwords of former employees should be immediately deactivated so they can no longer access the network.

Lexette (halobetasol propionate) foam 0.05% has been made available for patients 18 years of age and older for the topical treatment of plaque psoriasis.

Nuzyra, an aminomethylcycline (related to tetracycline antibiotics), is designed to overcome tetracycline resistance and has broad-spectrum activity against Gram-positive, Gram-negative and atypical bacteria, and other drug-resistant strains.